{
  "meta": {
    "timestamp": "2025-01-06T09:02:49.491240",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Fortrea Holdings Inc.",
      "symbol": "FTRE",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Regulatory and compliance risks due to adherence to GCP guidelines, FDA regulations, and Sarbanes-Oxley Act",
            "Client concentration and economic sensitivity, with reliance on a limited number of large pharmaceutical and biotech clients",
            "Intense competitive pressures from established CROs like IQVIA, Syneos Health, and Parexel",
            "Data privacy and cybersecurity risks from handling sensitive patient data",
            "Legal and shareholder concerns, including investigation by Pomerantz LLP for potential securities fraud or breaches of fiduciary duty",
            "Bearish market sentiment indicated by heavy put volume and high Put/Call Ratio"
          ],
          "controversies": [
            "Investigation by Pomerantz LLP for potential securities fraud or breaches of fiduciary duty",
            "Activist hedge funds targeting the company, indicating potential dissatisfaction with management or strategic direction"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Focus on diversity and inclusion in clinical trials, aligning with FDA guidance on Diversity Action Plans"
          ],
          "governance_issues": [
            "Potential breaches of fiduciary duty under investigation",
            "Activist investor involvement indicating governance concerns"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "PDF",
              "snippet": "In addition to mandating compliance with all applicable regulatory requirements, GCP guidelines address other critical aspects of clinical trial practices, including quality assurance, participant safety, informed consent and data integrity. About Fortrea We believe the exceptional is possible when you have Fortrea as your partner.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737537+00:00",
              "published_date": null,
              "source_hash": "38ff5a0ade28653e18204b3c82b9d4a0"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. SEC 10-Q Report \u2014 TradingView News",
              "snippet": "Fortrea Holdings Inc., a company specializing in phase I-IV clinical trials and comprehensive clinical development capabilities, has released its Form 10-Q report for the third quarter of 2024. ... Regulatory Compliance: As a public company, the company is subject to extensive regulatory requirements, including the Sarbanes-Oxley Act. Non ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737685+00:00",
              "published_date": null,
              "source_hash": "09499c1764739601d3f3abc2cd5d3a04"
            },
            {
              "url": "",
              "title": "SEC Filing - Fortrea",
              "snippet": "Fortrea Holdings Inc. (the \"Registrant\") will provide all participants in the Fortrea Holdings Inc. 2023 Omnibus Incentive Plan and the Fortrea Holdings Inc. 2023 Employee Stock Purchase Plan (as each may be amended from time to time, the \"Plans\") with the applicable document(s) containing the information required by Part I of Form S-8, as specified in Rule 428(b)(1) promulgated by the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737709+00:00",
              "published_date": null,
              "source_hash": "9a80bc36771997d3632dd6ae33d25973"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc Securities and Exchange Commission",
              "snippet": "stock of FORTREA HOLDINGS INC is more than five percent of the total outstanding common stock. Item 7. Identification and Classification of the Subsidiary Which ... United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737722+00:00",
              "published_date": null,
              "source_hash": "7709de58b86bdd76dd29429394f2af2d"
            },
            {
              "url": "",
              "title": "SEC Filing | Fortrea",
              "snippet": "Fortrea Holdings Inc. (the \"Company\") hereby provides responses to the comments received from the staff (the \"Staff\") of the United States Securities and Exchange Commission (the \"Commission\") set forth in the comment letter dated April 19, 2023 (the \"Comment Letter\") with respect to the above-referenced Amendment No. 1 to Draft Registration Statement on Form 10 (\"Amendment ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737733+00:00",
              "published_date": null,
              "source_hash": "dbfd1d3538249c55812a42ef74a3bf63"
            },
            {
              "url": "",
              "title": "Here's Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By ...",
              "snippet": "We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look at where Fortrea Holdings Inc. (NASDAQ:FTRE) stands against the other ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737744+00:00",
              "published_date": null,
              "source_hash": "e6bc514a53e06a0ef38a7bb6832a3807"
            },
            {
              "url": "",
              "title": "Regulatory Strategy - Fortrea",
              "snippet": "U.K.: Medicines and Healthcare products Regulatory Agency (MHRA) Regulatory strategy consulting: Access strategic advice for regulatory development pathways ; China: National Medical Products Administration (NMPA) Japan: Pharmaceuticals and Medical Devices Agency (PMDA); Ministry of Health, Labour and Welfare (MHLW)",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737775+00:00",
              "published_date": null,
              "source_hash": "5901dc3a77d741866dfce1f787f5167c"
            },
            {
              "url": "",
              "title": "Fitch Assigns Final Ratings to Fortrea Holdings, Inc.; Outlook Stable",
              "snippet": "Fortrea Holdings, Inc. is a CRO that provides clinical development and commercialization services and software applications supporting clinical trials to the biopharmaceutical and medical device industries. ... This means ESG issues are credit-neutral or have only a minimal credit impact on the entity, either due to their nature or the way in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737785+00:00",
              "published_date": null,
              "source_hash": "e1a4f78e3e261c89af7f1693cce81d1d"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc (NASDAQGS:FTRE) Market Cap",
              "snippet": "Fortrea Holdings Inc's Market Cap of 1.729 B ranks in the 90.4% percentile for the Sector. The following table provides additional summary stats: Market Cap In The Healthcare Sector;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737797+00:00",
              "published_date": null,
              "source_hash": "69f8b5e2848f60b00c7a632e04ed6a9f"
            },
            {
              "url": "",
              "title": "Hold Rating on Fortrea Holdings Amid Contracting Challenges and Revised ...",
              "snippet": "Deutsche Bank analyst Justin Bowers maintained a Hold rating on Fortrea Holdings Inc. (FTRE - Research Report) yesterday and set a price target of $28.00.. Justin Bowers has given his Hold ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:17.737808+00:00",
              "published_date": null,
              "source_hash": "ecce91e030dc5fd3d626a9746553382c"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc put volume heavy and directionally bearish",
              "snippet": "Bearish flow noted in Fortrea ( FTRE) Holdings Inc with 1,065 puts trading, or 1.0x expected. Most active are Jan-25 17.5 puts and Jan-25 20 puts, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 44.38, while ATM IV is up nearly 2 points on the day. Earnings are expected on March 10th.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:28.324971+00:00",
              "published_date": "2025-01-02T18:34:00+00:00",
              "source_hash": "d852d942a45dc7f1b36eeefb9f8349d7"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE",
              "snippet": "NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ:FTRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:24.241715+00:00",
              "published_date": "2025-01-03T17:08:00+00:00",
              "source_hash": "3b1e507ac5a3adc0f6e8d76681c82965"
            },
            {
              "url": "",
              "title": "Here's Why Fortrea Holdings Inc. (FTRE) Is Among The Stocks Targeted By Activist Hedge Funds",
              "snippet": "We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look at where Fortrea Holdings Inc. (NASDAQ:FTRE) stands against the other stocks targeted by activist hedge funds.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:28.325004+00:00",
              "published_date": "2025-01-03T11:29:54+00:00",
              "source_hash": "13395134c4fc0f57d60ece2e981d08dd"
            },
            {
              "url": "",
              "title": "Analysts Set Fortrea Holdings Inc. (NASDAQ:FTRE) Price Target at $23.30",
              "snippet": "Shares of Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) have been assigned a consensus recommendation of \"Reduce\" from the twelve brokerages that are covering the company, MarketBeat reports.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. regulatory compliance issues",
              "retrieved_at": "2025-01-06T16:02:20.292653+00:00",
              "published_date": "2024-12-23T05:29:00+00:00",
              "source_hash": "ab104b2fb0149eb2eeb9bbdebe926d8d"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Holdings Trimmed by Principal Financial Group Inc.",
              "snippet": "View Our Latest Stock Analysis on FTRE Fortrea Trading Up 1.2 % Fortrea stock opened at $18.65 on Wednesday. Fortrea Holdings Inc. has a 52 week low of $16.53 and a 52 week high of $41.02. The ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:24.241780+00:00",
              "published_date": "2025-01-01T00:00:00+00:00",
              "source_hash": "8fde310156267b74b194993e128b3e03"
            },
            {
              "url": "",
              "title": "Diversity & Inclusion in Clinical Trials - Fortrea",
              "snippet": "Leverage in-study diversity insights with the Fortrea Diversity and Inclusion Study Insights Dashboard. Leading the way on Diversity Action Plans On June 26, 2024, the U.S. FDA's draft guidance on improving diversity was published: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies .",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636042+00:00",
              "published_date": null,
              "source_hash": "0b04149a0f127392b98edd7797f898af"
            },
            {
              "url": "",
              "title": "Fortrea Introduces Comprehensive Solution to Improve - GlobeNewswire",
              "snippet": "Fortrea's D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636168+00:00",
              "published_date": null,
              "source_hash": "fe639c502ef0888304ad77fa4840e0f6"
            },
            {
              "url": "",
              "title": "Fortrea Introduces Comprehensive Solution to Improve Diversity and ...",
              "snippet": "Fortrea Holdings Inc. Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636188+00:00",
              "published_date": null,
              "source_hash": "27c87a6550addf16d4f708398a8f14ff"
            },
            {
              "url": "",
              "title": "Our Leadership | Fortrea",
              "snippet": "Drayton Virkler is President and Chief Commercial Officer at Fortrea, focused on improving the probability of success of biopharmaceutical companies across the globe as they bring life-saving and life-enhancing products to the market. Drayton joined the organization in May 2023 during Fortrea's spinoff from its parent company, Labcorp.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636203+00:00",
              "published_date": null,
              "source_hash": "156057cecac4a367d9305f7323776a77"
            },
            {
              "url": "",
              "title": "Narrow-Moat Fortrea Faces Challenges Associated With ... - Morningstar",
              "snippet": "Fortrea is a global, late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636219+00:00",
              "published_date": null,
              "source_hash": "304ce9b42b75b73cfeef57a92defdaf0"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) Company Profile & Overview - Stock Analysis",
              "snippet": "It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636230+00:00",
              "published_date": null,
              "source_hash": "47cdb1dae20d02174e07e8e99f191c30"
            },
            {
              "url": "",
              "title": "Fortrea (FTRE) Stock Price, News & Analysis - MarketBeat",
              "snippet": "It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636242+00:00",
              "published_date": null,
              "source_hash": "0b05e31e1f1b3e34d87002beff82e2cd"
            },
            {
              "url": "",
              "title": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of ...",
              "snippet": "Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. ... It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636310+00:00",
              "published_date": null,
              "source_hash": "3d6d8afe684769edae595700b37119ef"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc, FTRE:NSQ profile - FT.com - Financial Times",
              "snippet": "It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. ... Fortrea Holdings Inc 8 Moore Drive DURHAM 27709 United States USA; Fax +1 ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636322+00:00",
              "published_date": null,
              "source_hash": "e364358bf5da1b1ce9344faa78639b8a"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) Company Profile & Facts - Yahoo Finance",
              "snippet": "See the company profile for Fortrea Holdings Inc. (FTRE) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:21.636333+00:00",
              "published_date": null,
              "source_hash": "4d1906f7a536b75d17d77989cee1f1f3"
            },
            {
              "url": "",
              "title": "Fortrea's SWOT analysis: CRO stock faces challenges amid pharma strength",
              "snippet": "Fortrea Holdings Inc. (NYSE:FTRE), a clinically-focused contract ... offering a range of services to support drug development and clinical trials. With a global presence, the company has ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. clinical trial diversity controversies",
              "retrieved_at": "2025-01-06T16:02:24.241804+00:00",
              "published_date": "2024-12-13T01:03:00+00:00",
              "source_hash": "1db7ffe2fc5a6fe49f47177f2b2f94eb"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims ... - Morningstar",
              "snippet": "NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ: FTRE). Such investors are advised ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715324+00:00",
              "published_date": null,
              "source_hash": "bf83ae5608a0e23f82e29d890f4ce786"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. Company Profile - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Fortrea Holdings Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715437+00:00",
              "published_date": null,
              "source_hash": "3fd1225c42e0eb1ebccd3209bd1b40db"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) Statistics & Valuation Metrics - Stock ...",
              "snippet": "Detailed statistics for Fortrea Holdings Inc. (FTRE) stock, including valuation metrics, financial numbers, share information and more.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715454+00:00",
              "published_date": null,
              "source_hash": "550e92769941ed2d35fac89928568540"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...",
              "snippet": "NEW YORK, Jan. 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company\") (NASDAQ: FTRE).Such investors are advised ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715467+00:00",
              "published_date": null,
              "source_hash": "a9dd1de2758089faf44473b09d06be52"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc FTRE Overview - U.S. News",
              "snippet": "Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715477+00:00",
              "published_date": null,
              "source_hash": "21a8dc1f6403f02e37589bf3fb9d8b0e"
            },
            {
              "url": "",
              "title": "FTRE.N - | Stock Price & Latest News | Reuters",
              "snippet": "Get Fortrea Holdings Inc (FTRE.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715487+00:00",
              "published_date": null,
              "source_hash": "8f5598569712eae8a9619119ca99dbf8"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (FTRE) 10K Annual Reports & 10Q SEC Filings",
              "snippet": "The following information was filed by Fortrea Holdings Inc. (FTRE) on Monday, March 11, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715498+00:00",
              "published_date": null,
              "source_hash": "a97a6658b7c38b5c88b0afdd370c867e"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc, FTRE:NSQ profile - FT.com - Financial Times",
              "snippet": "Data from 30 Sep 2024 - 30 Sep 2024 Source: FactSet Research Systems Inc. Income statement (USD) Year on year Fortrea Holdings Inc had net income fall from a gain of 192.90m to a loss of 3.40m despite flat revenues.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715507+00:00",
              "published_date": null,
              "source_hash": "f7a8e01645b66dcd8bb7d67391756b08"
            },
            {
              "url": "",
              "title": "FTRE | Fortrea Holdings Inc. Financial Statements - WSJ",
              "snippet": "Fortrea Holdings Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View FTRE financial statements in full.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715516+00:00",
              "published_date": null,
              "source_hash": "b7a48e62933c203942085e2014d82cc2"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. Company Profile & Data: stocks, market cap ...",
              "snippet": "Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina. Top 1-year algo backtest: +265.99% $10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:25.715526+00:00",
              "published_date": null,
              "source_hash": "5051657e99d7cff3688b4cc6be9ee64f"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE",
              "snippet": "NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (\"Fortrea\" or the \"Company ... rights of the victims of securities fraud, breaches of fiduciary duty, and corporate ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:28.324867+00:00",
              "published_date": "2025-01-03T17:08:00+00:00",
              "source_hash": "e1f8c8a26ff75ae7635f9f1ad1aa49ff"
            },
            {
              "url": "",
              "title": "Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Holdings Trimmed by Principal Financial Group Inc.",
              "snippet": "According to data from MarketBeat.com, the company has an average rating of \"Hold\" and a consensus target price of $23.30. Fortrea stock opened at $18.65 on Wednesday. Fortrea Holdings Inc ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:28.325030+00:00",
              "published_date": "2025-01-01T00:00:00+00:00",
              "source_hash": "4bf8a1ba993436a3f803a44e92234277"
            },
            {
              "url": "",
              "title": "FTRE Fortrea Holdings Inc.",
              "snippet": "View Fortrea Holdings Inc. (FTRE) current and estimated P/E ratio data provided by Seeking Alpha.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Fortrea Holdings Inc. Fortrea Holdings Inc. data privacy breaches",
              "retrieved_at": "2025-01-06T16:02:28.325054+00:00",
              "published_date": "2024-12-18T00:00:00+00:00",
              "source_hash": "c1edc804c53969f7d4503c56389d355a"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Fortrea Holdings Inc. regulatory compliance issues",
              "rationale": "Investigate potential legal or regulatory challenges impacting operations",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Fortrea Holdings Inc. clinical trial diversity controversies",
              "rationale": "Assess concerns or criticisms regarding diversity and inclusion in clinical trials",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Fortrea Holdings Inc. data privacy breaches",
              "rationale": "Identify any incidents of data security or privacy violations",
              "priority": 1
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T09:02:49.491254",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}